Hong S - Search Results

1

Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer.

Hong S, Kang YA, Cho BC, Kim DJ. Hong S, et al. Yonsei Med J. 2012 Jan;53(1):111-7. doi: 10.3349/ymj.2012.53.1.111. Yonsei Med J. 2012. PMID: 22187240 Free PMC article.

2

The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.

Jung M, Jeung HC, Lee SS, Park JY, Hong S, Lee SH, Noh SH, Chung HC, Rha SY. Jung M, et al. Among authors: hong s. J Cancer Res Clin Oncol. 2010 Apr;136(4):517-26. doi: 10.1007/s00432-009-0684-3. Epub 2009 Sep 23. J Cancer Res Clin Oncol. 2010. PMID: 19774395

3

Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer.

Moon YW, Sohn JH, Kim YT, Chang H, Jeong JH, Lee YJ, Chang J, Kim SK, Jung M, Hong S, Choi SH, Kim JH. Moon YW, et al. Among authors: hong s. Anticancer Res. 2009 Oct;29(10):4243-9. Anticancer Res. 2009. PMID: 19846981 Free article.

4

Brain metastases from colorectal carcinoma: prognostic factors and outcome.

Jung M, Ahn JB, Chang JH, Suh CO, Hong S, Roh JK, Shin SJ, Rha SY. Jung M, et al. Among authors: hong s. J Neurooncol. 2011 Jan;101(1):49-55. doi: 10.1007/s11060-010-0214-9. Epub 2010 May 14. J Neurooncol. 2011. PMID: 20467783

5

Prognostic factors in small cell lung cancer: a new prognostic index in Korean patients.

Hong S, Cho BC, Choi HJ, Jung M, Lee SH, Park KS, Kim SK, Kim JH. Hong S, et al. Oncology. 2010;79(3-4):293-300. doi: 10.1159/000323333. Epub 2011 Mar 16. Oncology. 2010. PMID: 21412014

6

Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.

Jung M, Kim SH, Hong S, Kang YA, Kim SK, Chang J, Rha SY, Kim JH, Kim DJ, Cho BC. Jung M, et al. Among authors: hong s. Yonsei Med J. 2012 Sep;53(5):931-9. doi: 10.3349/ymj.2012.53.5.931. Yonsei Med J. 2012. Retraction in: Yonsei Med J. 2013 Jan 1;54(1):269. doi: 10.3349/ymj.2013.54.1.269 PMID: 22869475 Free PMC article. Retracted.

7

Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.

Jung M, Kim SH, Lee YJ, Hong S, Kang YA, Kim SK, Chang J, Rha SY, Kim JH, Kim DJ, Cho BC. Jung M, et al. Among authors: hong s. Exp Ther Med. 2011 Jul;2(4):685-693. doi: 10.3892/etm.2011.273. Epub 2011 May 12. Exp Ther Med. 2011. PMID: 22977560 Free PMC article.

8

Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors.

Kim SH, Kim JW, Hwang IG, Jang JS, Hong S, Kim TY, Baek JY, Shin SH, Sun S, Hong DS, Kim HJ, Hong YS, Woo IS, Lee JH, Kim JH. Kim SH, et al. Among authors: hong ds, hong s, hong ys. J Geriatr Oncol. 2019 Sep;10(5):749-756. doi: 10.1016/j.jgo.2019.03.015. Epub 2019 Apr 2. J Geriatr Oncol. 2019. PMID: 30952517

9

Incidence and Clinical Outcomes of Febrile Neutropenia in Adult Cancer Patients with Chemotherapy Using Korean Nationwide Health Insurance Database.

Kim D, Lee S, Youk T, Hong S. Kim D, et al. Among authors: hong s. Yonsei Med J. 2021 Jun;62(6):479-486. doi: 10.3349/ymj.2021.62.6.479. Yonsei Med J. 2021. PMID: 34027634 Free PMC article.

10

Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors.

Baek YH, Kang EJ, Hong S, Park S, Kim JH, Shin JY. Baek YH, et al. Among authors: hong s. Int J Cancer. 2022 Apr 15;150(8):1291-1300. doi: 10.1002/ijc.33892. Epub 2021 Dec 30. Int J Cancer. 2022. PMID: 34877670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,043 results

Search Page

Filters